STOCK TITAN
  1. Home
  2. Sec-filings
  3. JNJ
  4. [8-K] JOHNSON & JOHNSON Reports Material Event

[8-K] JOHNSON & JOHNSON Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock JNJ logo
Johnson & Johnson

NYSE:JNJ

JNJ Rankings

#21 Ranked by Market Cap
#1387 Ranked by Dividends

JNJ Latest News

Oct 14, 2025
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2025
Oct 14, 2025
Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business
Oct 14, 2025
Johnson & Johnson Reports Q3 2025 Results; Raises 2025 Sales Outlook
Oct 10, 2025
Johnson & Johnson recommends shareholders reject “mini-tender” offer by Tutanota
Oct 10, 2025
Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress

JNJ Latest SEC Filings

Sep 15, 2025
[Form 3] JOHNSON & JOHNSON Initial Statement of Beneficial Ownership
Sep 15, 2025
[Form 3] JOHNSON & JOHNSON Initial Statement of Beneficial Ownership
Sep 11, 2025
[Form 4] Johnson & Johnson Insider Trading Activity
Sep 11, 2025
[Form 4] Johnson & Johnson Insider Trading Activity
Sep 11, 2025
[Form 4] Johnson & Johnson Insider Trading Activity

JNJ Stock Data

459.32B
2.41B
0.06%
74.37%
0.78%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
NEW BRUNSWICK